4//SEC Filing
Colangelo Dominick 4
Accession 0001140361-25-019474
CIK 0000887359other
Filed
May 15, 8:00 PM ET
Accepted
May 16, 4:06 PM ET
Size
13.7 KB
Accession
0001140361-25-019474
Insider Transaction Report
Form 4
Vericel CorpVCEL
Colangelo Dominick
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2025-05-14$2.65/sh+14,062$37,264→ 274,416 total - Sale
Common Stock
2025-05-14$42.25/sh−14,062$594,120→ 260,354 total - Exercise/Conversion
Common Stock
2025-05-15$2.65/sh+14,063$37,267→ 274,417 total - Sale
Common Stock
2025-05-15$41.53/sh−14,063$584,036→ 260,354 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-05-14+14,062→ 14,063 totalExercise: $2.65→ Common Stock (14,062 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2025-05-15+14,063→ 0 totalExercise: $2.65→ Common Stock (14,063 underlying)
Footnotes (4)
- [F1]These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F2]The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2024.
- [F3]6.25% of these options, representing the right to purchase a total of 90,000 shares, became exercisable immediately on May 22, 2017. An additional 6.25% became exercisable on August 8, 2017 and continued to vest in equal quarterly installments from August 8, 2017, contingent upon continued service to the Company.
- [F4]These options, which were awarded on May 22, 2017, would otherwise expire and become forfeitable on May 22, 2027.
Documents
Issuer
Vericel Corp
CIK 0000887359
Entity typeother
Related Parties
1- filerCIK 0001313403
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 4:06 PM ET
- Size
- 13.7 KB